Details of the Drug

General Information of Drug (ID: DMDM2DF)

Drug Name
CLR-131
Indication
Disease Entry ICD 11 Status REF
Haematological malignancy 2B33.Y Phase 2 [1]
Multiple myeloma 2A83 Phase 2 [1]
Pediatric cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
16045365
TTD ID
D0RX6F
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)